A new mouse model of type 2 diabetes mellitus established through combination of high-fat diet, streptozotocin and glucocorticoid
Authors:
- 1 December 2021
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 286, 120062
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81673248)
This publication has 27 references indexed in Scilit:
- Effects of saxagliptin and sitagliptin on glycaemic control and pancreatic β‐cell mass in a streptozotocin‐induced mouse model of type 2 diabetesDiabetes, Obesity and Metabolism, 2012
- The effects of glucocorticoids on adipose tissue lipid metabolismMetabolism, 2011
- Experimental rodent models of type 2 diabetes: A reviewMethods and Findings in Experimental and Clinical Pharmacology, 2009
- Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndromeJournal of Endocrinology, 2008
- Dexamethasone-induced insulin resistance is associated with increased connexin 36 mRNA and protein expression in pancreatic rat isletsCanadian Journal of Physiology and Pharmacology, 2007
- Reactive oxygen species have a causal role in multiple forms of insulin resistanceNature, 2006
- Molecular mechanisms of insulin resistanceDiabetic Medicine, 2005
- Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats.Journal of Clinical Investigation, 1993
- Roles of insulin resistance and beta-cell dysfunction in dexamethasone-induced diabetes.Journal of Clinical Investigation, 1992
- Streptozotocin and alloxan induce DNA strand breaks and poly(ADP–ribose) synthetase in pancreatic isletsNature, 1981